ResearcherKerman University of Medical SciencesActive in the last 2 years
Ali Afgar
Matched on ORCID iD 0000-0002-4487-8523; OpenAlex author ID A5057060526.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 1, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 3
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 2
- Computational and experimental evaluation of curcumin as a DNMT3B-targeting epigenetic modulator in pancreatic cancer. First author DOI 10.1007/s40203-026-00717-1↗
- MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic … Co-author DOI 10.1007/s00280-017-3418-2↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Batoul Kavyani · 1 shared paper, 2026
- Ladan Teimoori-Toolabi · 1 shared paper, 2017
- Azam Rajabpour · 1 shared paper, 2017
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.